Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · February 25, 2023

Efficacy and Safety of Pegylated Interferon Lambda for Early Treatment of COVID-19

The New England Journal of Medicine


Additional Info

Disclosure statements are available on the authors' profiles:

The New England Journal of Medicine
Early Treatment with Pegylated Interferon Lambda for Covid-19
N. Engl. J. Med 2023 Feb 09;388(6)518-528, G Reis, EAS Moreira Silva, DC Medeiros Silva, L Thabane, VHS Campos, TS Ferreira, CVQ Santos, AMR Nogueira, APFG Almeida, LCM Savassi, AD Figueiredo-Neto, ACF Dias, AM Freire Júnior, C Bitarães, AC Milagres, ED Callegari, MIC Simplicio, LB Ribeiro, R Oliveira, O Harari, LA Wilson, JI Forrest, H Ruton, S Sprague, P McKay, CM Guo, EH Limbrick-Oldfield, S Kanters, GH Guyatt, CR Rayner, C Kandel, MJ Biondi, R Kozak, B Hansen, MA Zahoor, P Arora, C Hislop, I Choong, JJ Feld, EJ Mills, JS Glenn

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading